Delivery Order SPE2DB22D2206-SPE2DB25FGS58
- Not listed
- The Defense Logistics Agency awarded a $13,161.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ethacrynate Sodium 50 mg vials, with an ultimate completion date of October 31, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location and is issued as a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $7,878.40 to AmerisourceBergen Drug Corp for the supply of Ethacrynate Sodium 50 mg vials. The contract employs firm fixed pricing with a delivery completion deadline of September 2, 2025. This non-competitive, non-set-aside delivery order leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion pharmaceutical prime vendor agreement extending through December...
- The Defense Logistics Agency awarded a $11,673.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ethacrynate Sodium 50 mg vials. The award, issued on October 22, 2025, with an ultimate completion date of October 23, 2025, represents a non-competitive delivery order with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- This is a $41,217.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ETHACRYNATE SODIUM 50 MG VIALS, a pharmaceutical product, with a final completion date of June 27, 2025. The contract is not set aside and represents an open competition award. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4,564,288,053 units of Ethacrynate Sodium 50 mg vials, a pharmaceutical product, with a ceiling value of $18,407.94. The contract has a firm fixed price pricing type and an ultimate completion date of April 16, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S....
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,650.29 delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of Sodium Tetrasulfate 3% 60mg/2ml in 2ml units. This firm fixed-price, competitively awarded delivery order is set to be completed by June 10, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive role as a critical pharmaceutical vendor...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,004.85 to AmerisourceBergen Drug Corp on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitive award to the prime contractor under its broader contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,699.90 to AmerisourceBergen Drug Corp for the supply of Chlorothiazide Sodium 500 mg vials. This non-set-aside, competitively awarded delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The contract utilizes firm fixed pricing and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 30, 2025, represents a $1,576.31 firm fixed-price procurement from the Defense Logistics Agency's Medical Supply Chain. The contract is unset-aside and competitively awarded, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of July 31, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $43,665.88 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitively awarded transaction under a larger indefinite delivery contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FGS58Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Ethacrynate Sodium 50 mg vials, a loop diuretic medication used in acute medical settings. This firm fixed price delivery order is valued at $20,241.83 with an ultimate completion date of April 25, 2025, and represents a non-competitive set-aside award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999,999,999.00 and active through December 2026. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement across the Defense Health Agency and other military healthcare systems. The company's existing IDC vehicle enables rapid fulfillment of pharmaceutical and medical supply requirements across multiple therapeutic domains on a global basis. This delivery order exemplifies the operational efficiency of the prime vendor model, allowing DLA to procure essential medications through an established contractor relationship with demonstrated capability in supporting military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.2k | 4/24/25 |